You are here:

  1. Home
  2. NICE guidance
  3. In development

Waldenstrom’s macroglobulinaemia - ibrutinib [ID884]

  • In development
  • Reference number: GID-TA10046
  • Expected publication date:  22 November 2017
  • Project information
  • Project documents

On this page

  1. Final appraisal determination
  2. Draft guidance
  3. Draft scope documents

Documents

Documents created during the development process.

Final appraisal determination

  • Final appraisal determination

  • Committee papers (PDF 2.46 MB)

    Published:
    28 September 2017
  • Final appraisal determination document (PDF 420 KB)

    Published:
    28 September 2017
  • Committee papers Presentation Slides (PDF 594 KB)

    Published:
    28 September 2017
  • Final appraisal determination document Managed Access Agreement (PDF 827 KB)

    Published:
    28 September 2017
  • Final appraisal determination document CDF Glossary of Terms (PDF 125 KB)

    Published:
    28 September 2017

Draft guidance

  • Draft guidance

  • Committee papers (PDF 15.69 MB)

    Published:
    12 October 2016
  • Appraisal consultation document (PDF 296 KB)

    Published:
    12 October 2016
  • Committee papers Clinical Presentation Slides (PDF 452 KB)

    Published:
    12 October 2016
  • Committee papers Cost presentation slides (PDF 484 KB)

    Published:
    12 October 2016

Draft scope documents

  • Draft scope (pre-referral) (PDF 169 KB)

    Published:
    05 April 2016
  • Provisional matrix (pre-referral) (PDF 154 KB)

    Published:
    05 April 2016
Back to top